We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$14.6B
AUM Growth
+$1.24B
Cap. Flow
+$998M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.27%
Holding
2,202
New
241
Increased
1,177
Reduced
603
Closed
133

Sector Composition

Rank Sector Weight
1 Energy 9.2%
2 Healthcare 8.03%
3 Technology 7.82%
4 Financials 7.64%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESLT icon
1551
Elbit Systems
ESLT
$40.3B
$779K 0.01%
12,799
-291
-2% -$17.1K
SCHB icon
1552
Schwab US Broad Market ETF
SCHB
$44.9B
$777K 0.01%
+101,988
New +$763K
VALE icon
1553
Vale
VALE
$62.6B
$775K 0.01%
56,003
-21,666
-28% -$296K
VIVS
1554
VivoSim Labs
VIVS
$1.64M
$773K 0.01%
+422
New +$980K
TWM icon
1555
ProShares UltraShort Russell2000
TWM
$41.3M
$771K 0.01%
+841
New +$800K
LOR
1556
DELISTED
Lazard World Dividend & Income Fund, Inc.
LOR
$771K 0.01%
55,369
+1,487
+3% +$20.7K
ENOC
1557
DELISTED
EnerNOC, Inc.
ENOC
$771K 0.01%
34,597
-116,503
-77% -$2.47M
SGY
1558
DELISTED
Stone Energy
SGY
$771K 0.01%
323
+32
+11% +$62.7K
TIVO
1559
DELISTED
Tivo Inc
TIVO
$768K 0.01%
33,694
+12,294
+57% +$282K
IEUS icon
1560
iShares MSCI Europe Small-Cap ETF
IEUS
$185M
$762K 0.01%
16,367
-727
-4% -$33K
NZF icon
1561
Nuveen Municipal Credit Income Fund
NZF
$2.45B
$762K 0.01%
58,165
+28,570
+97% +$369K
PRLB icon
1562
Protolabs
PRLB
$2.13B
$762K 0.01%
11,266
-22,647
-67% -$1.68M
SMG icon
1563
ScottsMiracle-Gro
SMG
$3.66B
$762K 0.01%
+12,433
New +$738K
ZBRA icon
1564
Zebra Technologies
ZBRA
$17.8B
$762K 0.01%
10,974
-147
-1% -$9.01K
BCX icon
1565
BlackRock Resources & Commodities Strategy Trust
BCX
$923M
$761K 0.01%
66,134
+17,385
+36% +$198K
VTLE
1566
DELISTED
Vital Energy
VTLE
$759K 0.01%
+1,468
New +$750K
ISH
1567
DELISTED
INTL SHIPHOLDING CORP
ISH
$755K 0.01%
25,644
-1,205
-4% -$34.3K
ROC
1568
DELISTED
ROCKWOOD HLDGS INC
ROC
$755K 0.01%
+10,150
New +$748K
RMD icon
1569
ResMed
RMD
$30.7B
$754K 0.01%
16,870
-29,055
-63% -$1.31M
XRAY icon
1570
Dentsply Sirona
XRAY
$2.43B
$754K 0.01%
16,371
+771
+5% +$35.7K
BBN icon
1571
BlackRock Taxable Municipal Bond Trust
BBN
$986M
$751K 0.01%
37,110
-530
-1% -$10.4K
JHP
1572
DELISTED
NUVEEN QUALITY PREFERRED INCOME FUND 3
JHP
$750K 0.01%
+89,649
New +$729K
MYI icon
1573
BlackRock MuniYield Quality Fund III
MYI
$721M
$749K 0.01%
55,056
-639
-1% -$8.45K
BYM
1574
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$748K 0.01%
55,175
+6,625
+14% +$88.9K
MGC icon
1575
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
$748K 0.01%
11,710
+381
+3% +$23.9K

Similar funds

Raymond James & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Raymond James & Associates held 2,202 positions worth $14.6B, up 9.3% from $13.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $998M of net new capital in Q1 2014, opening 241 new positions and adding to 1,177 existing holdings. Its largest new stake was Edgewell Personal Care: 199,912 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 9.2% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vodafone, an estimated $33.9M trimmed.

  • Raymond James & Associates's largest Q1 2014 buy was Edgewell Personal Care: 199,912 shares worth $14.9M.
  • Raymond James & Associates added most to Verizon in Q1 2014, an estimated $31.6M increase.
  • Raymond James & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $33.9M.
  • Raymond James & Associates fully exited Nu Skin in Q1 2014, selling an estimated $5.53M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2014.
  • Raymond James & Associates opened 241 new positions and closed 133 in Q1 2014.
  • Raymond James & Associates's portfolio value rose 9.3% quarter-over-quarter to $14.6B.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.